Applied Therapeutics, Inc. Common Stock
Symbol: APLT (NASDAQ)
0.45
▲ (0.79%) 0.004
Company Description:
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
Key Stats
- Today's Open: $0.455
- Today's High: $0.461
- Today's Low: $0.438
- Today's Volume: 164.73K
- Yesterday Close: $0.4445
- Yesterday High: $0.459
- Yesterday Low: $0.4302
- Yesterday Volume: 719.26K
- Last Min Volume: 100
- Last Min High: $0.448
- Last Min Low: $0.448
- Last Min VWAP: $0.448
Company Profile
- Name: Applied Therapeutics, Inc. Common Stock
- Website: https://www.appliedtherapeutics.com
- Listed Date: 2019-05-13
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0001697532
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $64.01M
- Round Lot: 100
- Outstanding Shares: 144.01M
- Asset Type: CS
RECENT FILINGS FOR APLT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-29 | 8-K | View |
| 2025-08-29 | 424B5 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | 8-K | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-13 | 8-K | View |
| 2025-08-12 | 8-K | View |
| 2025-07-29 | SCHEDULE 13G/A | View |
| 2025-07-16 | SCHEDULE 13G/A | View |
| 2025-07-03 | 4 | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 3 | View |
| 2025-06-17 | 8-K | View |
| 2025-06-12 | 8-K | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-14 | 10-Q | View |
Latest News on APLT